Immunodominance hierarchy after seasonal influenza vaccination

被引:8
作者
Sanchez-de Prada, Laura [1 ,2 ]
Sanz-Munoz, Ivan [1 ]
Ortiz de Lejarazu, Raul [1 ]
Maria Eiros, Jose [1 ]
Garcia-Sastre, Adolfo [3 ,4 ,5 ,6 ,7 ]
Aydillo, Teresa [3 ,4 ]
机构
[1] Natl Influenza Ctr Valladolid, Valladolid, Spain
[2] Hosp Clin Univ Valladolid, Dept Microbiol, Valladolid, Spain
[3] Icahn Sch Med Mt Sinai, Dept Microbiol, 1 Gustave L Levy Pl, New York, NY 10029 USA
[4] Icahn Sch Med Mt Sinai, Global Hlth & Emerging Pathogens Inst, New York, NY 10029 USA
[5] Icahn Sch Med Mt Sinai, Dept Pathol Mol & Cell Based Med, New York, NY 10029 USA
[6] Icahn Sch Med Mt Sinai, Dept Med, Div Infect Dis, New York, NY 10029 USA
[7] Icahn Sch Med Mt Sinai, Tisch Canc Inst, New York, NY 10029 USA
关键词
Immunodominance; hemagglutinin; influenza; vaccines; adjuvants; ANTIGENIC STRUCTURE; MF59(R) ADJUVANT; B-CELLS; VIRUS; HEMAGGLUTININ; ANTIBODIES; IMMUNOSENESCENCE; PROTECTION; INFECTION;
D O I
10.1080/22221751.2022.2135460
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Current influenza vaccines elicit humoral immune responses against the haemagglutinin (HA) protein of influenza viruses. Different antigenic sites have been identified in the HA head as the main target of haemagglutination inhibition (HAI) antibodies (Sb, Sa, Cb, Ca1 and Ca2). To determine immunodominance (ID) of each site, we performed HAI assays against a panel of mutant viruses, each one lacking one of the classically defined antigenic sites and compared it to wild type (Wt). Agglutinating antibodies were measured before and after vaccination in two different regimens: Quadrivalent Influenza Vaccine (QIV) in young adults; or Adjuvanted Trivalent influenza Vaccine (ATIV) in elderly. Our results showed abs before vaccination were significantly reduced against all antigenic sites in the elderly and only against Sb and Ca2 in young adults compared to the Wt. Humoral response to vaccination was significantly reduced against all viruses compared to the Wt for the ATIV and only against Sb and Ca2 for the QIV. The strongest reduction was observed in all cases against Sb followed by Ca2. We concluded that ID profile was clearly dominated by Sb followed by Ca2. Additionally, the antibody response evolved with age, increasing the response towards less immunodominant epitopes of HA head. Adjuvants can positively influence ID hierarchy broadening responses towards multiple antigenic sites of HA head.
引用
收藏
页码:2670 / 2679
页数:10
相关论文
共 43 条
[1]   Antibody Immunodominance: The Key to Understanding Influenza Virus Antigenic Drift [J].
Altman, Meghan O. ;
Angeletti, Davide ;
Yewdell, Jonathan W. .
VIRAL IMMUNOLOGY, 2018, 31 (02) :142-149
[2]   Is It Possible to Develop a "Universal" Influenza Virus Vaccine? Outflanking Antibody Immunodominance on the Road to Universal Influenza Vaccination [J].
Angeletti, Davide ;
Yewdell, Jonathan W. .
COLD SPRING HARBOR PERSPECTIVES IN BIOLOGY, 2018, 10 (07)
[3]   Understanding and Manipulating Viral Immunity: Antibody Immunodominance Enters Center Stage [J].
Angeletti, Davide ;
Yewdell, Jonathan W. .
TRENDS IN IMMUNOLOGY, 2018, 39 (07) :549-561
[4]   Defining B cell immunodominance to viruses [J].
Angeletti, Davide ;
Gibbs, James S. ;
Angel, Matthew ;
Kosik, Ivan ;
Hickman, Heather D. ;
Frank, Gregory M. ;
Das, Suman R. ;
Wheatley, Adam K. ;
Prabhakaran, Madhu ;
Leggat, David J. ;
McDermott, Adrian B. ;
Yewdell, Jonathan W. .
NATURE IMMUNOLOGY, 2017, 18 (04) :456-+
[5]  
[Anonymous], 2011, Manual for the laboratory diagnosis and virological surveillance of influenza, P153, DOI DOI 10.1016/J.JPAIN.2013.01.631
[6]   Pre-existing Hemagglutinin Stalk Antibodies Correlate with Protection of Lower Respiratory Symptoms in Flu-Infected Transplant Patients [J].
Aydillo, Teresa ;
Escalera, Alba ;
Strohmeier, Shirin ;
Aslam, Sadaf ;
Sanchez-Cespedes, Javier ;
Ayllon, Juan ;
Roca-Oporto, Cristina ;
Perez-Romero, Pilar ;
Montejo, Miguel ;
Gavalda, Joan ;
Munoz, Patricia ;
Lopez-Medrano, Francisco ;
Carratala, Jordi ;
Krammer, Florian ;
Garcia-Sastre, Adolfo ;
Cordero, Elisa .
CELL REPORTS MEDICINE, 2020, 1 (08)
[7]   Repeated annual influenza vaccination and vaccine effectiveness: review of evidence [J].
Belongia, Edward A. ;
Skowronski, Danuta M. ;
McLean, Huong Q. ;
Chambers, Catharine ;
Sundaram, Maria E. ;
De Serres, Gaston .
EXPERT REVIEW OF VACCINES, 2017, 16 (07) :723-736
[8]   THE ANTIGENIC STRUCTURE OF THE INFLUENZA-VIRUS A/PR/8/34 HEMAGGLUTININ (H-1 SUBTYPE) [J].
CATON, AJ ;
BROWNLEE, GG ;
YEWDELL, JW ;
GERHARD, W .
CELL, 1982, 31 (02) :417-427
[9]   Superior immunogenicity of seasonal influenza vaccines containing full dose of MF59® adjuvant Results from a dose-finding clinical trial in older adults [J].
Della Cioppa, Giovanni ;
Nicolay, Uwe ;
Lindert, Kelly ;
Leroux-Roels, Geert ;
Clement, Frederic ;
Castellino, Flora ;
Galli, Grazia ;
Groth, Nicola ;
Del Giudice, Giuseppe .
HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2012, 8 (02) :216-227
[10]   A Universal Influenza Vaccine: The Strategic Plan for the National Institute of Allergy and Infectious Diseases [J].
Erbelding, Emily J. ;
Post, Diane J. ;
Stemmy, Erik J. ;
Roberts, Paul C. ;
Augustine, Alison Deckhut ;
Ferguson, Stacy ;
Paules, Catharine I. ;
Graham, Barney S. ;
Fauci, Anthony S. .
JOURNAL OF INFECTIOUS DISEASES, 2018, 218 (03) :347-354